Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease (COPD): Occurrence Frequency and the Effect of Treatment With the Inhaled Long-Acting Beta2-Agonists Arformoterol and Salmeterol
暂无分享,去创建一个
P. Zimetbaum | J. Hanrahan | J. Morganroth | D. Grogan | R. Baumgartner | Hailong Cheng | Amy Wilson
[1] S. Sahn,et al. Effect of Nebulized Arformoterol on Airway Function in COPD: Results from Two Randomized Trials , 2008, COPD.
[2] G. Criner,et al. Cardiac safety of formoterol 12 microg twice daily in patients with chronic obstructive pulmonary disease. , 2007, Pulmonary pharmacology & therapeutics.
[3] S. Sahn,et al. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. , 2007, Clinical therapeutics.
[4] N. Anthonisen,et al. Mortality in COPD: role of comorbidities , 2006, European Respiratory Journal.
[5] A. Hofman,et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.
[6] A. Hansell,et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. , 2005, Chest.
[7] S. Suissa,et al. Cardiovascular morbidity and mortality in COPD. , 2005, Chest.
[8] L. Trupin,et al. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease , 2005, Environmental health : a global access science source.
[9] D. Sin,et al. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. , 2005, Proceedings of the American Thoracic Society.
[10] E. Salpeter,et al. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. , 2004, Chest.
[11] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[12] L. Trupin,et al. The occupational burden of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[13] C. Funck-Brentano,et al. Cardiovascular safety of salmeterol in COPD. , 2003, Chest.
[14] W. MacNee,et al. Chronic obstructive pulmonary disease • 7: Management of COPD , 2003, Thorax.
[15] D. Postma,et al. Chronic obstructive pulmonary disease. , 2002, Clinical evidence.
[16] Edwin K Silverman,et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. , 2002, American journal of human genetics.
[17] R. Dahl,et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[18] GunnarEngström,et al. Occurrence and Prognostic Significance of Ventricular Arrhythmia Is Related to Pulmonary Function , 2001 .
[19] B. Hedblad,et al. Occurrence and Prognostic Significance of Ventricular Arrhythmia Is Related to Pulmonary Function: A Study From “Men Born in 1914,” Malmö, Sweden , 2001, Circulation.
[20] T L Petty,et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.
[21] P. Jones,et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.
[22] S. Yancey,et al. Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.
[23] M. Cazzola,et al. Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia. , 1998, Chest.
[24] Association World Medical,et al. World medical association declaration of Helsinki , 2001, Chinese Journal of Integrative Medicine.
[25] W. L. Ooi,et al. Twenty-four-hour ambulatory electrocardiography in elderly subjects: prevalence of various arrhythmias and prognostic implications (report from the Bronx Longitudinal Aging Study). , 1996, American heart journal.
[26] P. Howard,et al. The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD. , 1995, Respiratory medicine.
[27] P M Rautaharju,et al. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study. , 1994, Journal of the American College of Cardiology.
[28] J. Fleg,et al. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. , 1983, Chest.
[29] S. Glasser,et al. Occurrence of frequent complex arrhythmias detected by ambulatory monitoring: findings in an apparently healthy asymptomatic elderly population. , 1979, Chest.
[30] R. Kleiger,et al. Longterm electrocardiographic monitoring of ambulatory patients with chronic airway obstruction. , 1974, Chest.